After studying the results of 3 brief cognitive assessments administered to more than 800 patients, researchers determined whether the tests could accurately classify dementia.
The FDA has released a warning about the potential for an increase in disability in patients with multiple sclerosis who stop taking this immunosuppressant.
Researchers of a study presented at the APHA Annual Meeting & Expo determined whether patients with dementia experience certain symptoms at a higher rate than those without the condition.
Researchers at the APHA’s Annual Meeting & Expo presented their findings on the connection between risk factors for cognitive decline and cardiovascular disease.
As marijuana continues to be legalized in more areas of the United States, it is important to clarify its association with major health outcomes, including stroke. Researchers investigated this further in a...
By reviewing data from recent clinical trials, researchers sought to determine whether medicinal cannabinoids help alleviate multiple sclerosis symptoms.
